Neurostyle Pte Ltd

Neurostye was featured in Medical Fair Asia as a rapid growing company with research partners

SINGAPORE: The medical technology (medtech) sector is expected to grow from US$88 billion (S$120 billion) in 2015 to US$133 billion in 2020 in Asia Pacific, and Singapore is "well-positioned" to act as a gateway to tap the market in the region, said Minister for Trade and Industry (Industry) S Iswaran at a medtech showcase on Wednesday (Aug 31).

To overcome challenges Medtech companies faced, Singapore Government is also providing assistance through grants and schemes.

One company which has tapped such support is Neurostyle. Together with A*STAR's Institute of Infocomm Research, it has come up with a system to rehabilitate stroke patients. A clinical trial, which is underway at Tan Tock Seng Hospital, gets stroke patients to imagine moving their limbs.

Dr Johnson Lu, director of Neurostyle, explained: "The system understands the brain's imagination, the status of the affected patient's brain imagination status, and integrates with the physical rehabilitation means. When these two combine together, we exercise the brain and the limb together. After a few rounds, after one and a half months, we see a very good progress in the recovery of the stroke patients.

Exhibitor Data Sheet